Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation
ApprovedCompleted 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Dry Eye Syndromes
Conditions
Dry Eye Syndromes
Trial Timeline
Aug 1, 2020 → Jul 1, 2021
NCT ID
NCT04413279About Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation
Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation is a approved stage product being developed by Ocular Therapeutix for Dry Eye Syndromes. The current trial status is completed. This product is registered under clinical trial identifier NCT04413279. Target conditions include Dry Eye Syndromes.
What happened to similar drugs?
14 of 20 similar drugs in Dry Eye Syndromes were approved
Approved (14) Terminated (3) Active (5)
Hype Score Breakdown
Clinical
20
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04413279 | Approved | Completed |
Competing Products
20 competing products in Dry Eye Syndromes